CRISPR Therapeutics AG (CRSP) is Attracting Investor Attention: Here is What You Should Know
CRISPR Therapeutics (CRSP) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
CRISPR Therapeutics AG (CRSP) TD Cowen 45th Annual Healthcare Conference (Transcript)
CRISPR Therapeutics AG ( NASDAQ: CRSP) TD Cowen 45th Annual Healthcare Conference March 3, 2025 10:30 AM ET ...
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Fulgent Genetics (FLGT), Alignment Healthcare (ALHC) and Syndax Pharmaceuticals (SNDX)
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Fulgent Genetics (FLGT – Research Report), Alignment ...
Twist Bioscience Co. (NASDAQ:TWST) Receives Consensus Recommendation of “Moderate Buy” from Analysts
Twist Bioscience Co. (NASDAQ:TWST – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the ten ratings firms that are covering the firm, Ratings reports. One investment ...
AbbVie Joins Obesity Treatment Market With Up to $2.2B Licensing Deal
Drugmaker AbbVie has agreed to license a weight-loss drug currently in development from Gubra for up to about $2.2 billion, ...
Global In Situ Hybridization Market to Grow at a CAGR of ~7% by 2032 | DelveInsight
DelveInsight's In Situ Hybridization Market Insights report provides the current and forecast market analysis, individual ...
DelveInsight Business Research, LLP: Global In Situ Hybridization Market to Grow at a CAGR of ~7% by 2032 | DelveInsight
The demand for in situ hybridization is experiencing significant growth, mainly due to the rising rates of cancer and genetic disorders. This trend is further driven by the increasing incidence ...